Klona Biotech
PrivateLast Round
Grant
Aug 25, 2026
Total Funding Raised
$1.54M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Klona Biotech operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Grant round in August 2026.
Klona Biotech is a biotechnology company that develops a bioprinting platform for the decentralized manufacturing of regenerative, patient-specific medical implants for structural tissues such as tendons and ligaments.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, 3D Printing, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Klona Biotech Comparables
Compare Klona Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nanochon | 79% | |
| PrintBio, Inc. | 79% | |
| A.D.A.M. Bioprinting | 79% |
For institutional investors. Book with your work email.
Klona Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 25, 2026 | ||||
| Pre Seed | Nov 25, 2025 |
For institutional investors. Book with your work email.
Klona Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Arben Ventures | Pre Seed |
| Outset Ventures | Pre Seed |
| Zee Prime Capital | Pre Seed |
| Innovate UK | Grant |
| Draper Associates | Pre Seed |
| SOSV | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 25, 2026
$135K grant received from Innovate UK.
- Jul 24, 2026
Monthly visitors increased 248% MoM, reaching 899.
For institutional investors. Book with your work email.
Klona Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Klona Biotech's valuation, stock price, and market status.
Is Klona Biotech a public or private company?
Klona Biotech is a private company.
What is the current stock price of Klona Biotech?
Klona Biotech is a private company, so its shares have no public market price. Caplight tracks Klona Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Klona Biotech worth (valuation)?
Valuation information for Klona Biotech is not publicly available.
Can I buy Klona Biotech stock?
Klona Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Klona Biotech's last funding round?
Klona Biotech's most recent funding round was Grant on August 25, 2026.
Who are the main investors in Klona Biotech?
Key investors in Klona Biotech include Arben Ventures, Outset Ventures, Zee Prime Capital, Innovate UK, Draper Associates.
Will Klona Biotech IPO soon?
No public IPO plans have been announced for Klona Biotech.
How can I track Klona Biotech secondary market activity?
Caplight tracks bids, offers, and trades in Klona Biotech's shares on secondary markets.